Wall Street started the week on a muted note, with major indices little changed as investors looked ahead to a critical speech by Fed Chair Jerome Powell and a raft of retail earnings.

Eli Lilly looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbound and ...

Awkward. And the problem is this backdrop is occurring while stocks have pushed ever higher, leaving the S&P 500's SPX trailing earnings per share multiple at 25.5, Emanuel notes. That's "among the ...

European shares were subdued on Monday, ahead of key meetings between Ukraine, European leaders and US President Donald Trump ...

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

While health insurance premiums have been increasing, 2026 will see the largest hike in prices since 2018, according to KFF ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

NVIDIA Corporation, Novo Nordisk A/S, Shift4 Payments Inc, Hims Hers Health Inc. Read 's Market Analysis on Investing.com ...

Sensex climbed more than 1,100 points at its peak and the Nifty briefly touched the 25,000 mark on Monday, lifted by easing ...

The company that owns Chrysler, Dodge, Jeep, Ram and Fiat reported a 10% decrease in sales in 2025's second quarter.